Alistair Wilson

546 total citations
7 papers, 441 citations indexed

About

Alistair Wilson is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Neurology. According to data from OpenAlex, Alistair Wilson has authored 7 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Cognitive Neuroscience and 2 papers in Neurology. Recurrent topics in Alistair Wilson's work include Nerve injury and regeneration (6 papers), Autism Spectrum Disorder Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Alistair Wilson is often cited by papers focused on Nerve injury and regeneration (6 papers), Autism Spectrum Disorder Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Alistair Wilson collaborates with scholars based in United States and United Kingdom. Alistair Wilson's co-authors include Christopher D. Herzog, Raymond T. Bartus, Jeffrey H. Kordower, Lamar Brown, Eugene M. Johnson, Kathie M. Bishop, João Siffert, Mehdi Gasmi, Marie A. Printz and Elliott J. Mufson and has published in prestigious journals such as Brain Research, Neurosurgery and Movement Disorders.

In The Last Decade

Alistair Wilson

7 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair Wilson United States 7 317 183 157 132 94 7 441
Lamar Brown United States 8 295 0.9× 178 1.0× 174 1.1× 126 1.0× 92 1.0× 8 441
Tiffany Baumann United States 8 307 1.0× 154 0.8× 281 1.8× 155 1.2× 83 0.9× 9 580
Patricia E. McDermott United States 8 370 1.2× 140 0.8× 193 1.2× 41 0.3× 39 0.4× 10 558
Aaron Rising United States 8 185 0.6× 75 0.4× 240 1.5× 147 1.1× 46 0.5× 10 410
Marzia Indrigo Italy 8 179 0.6× 134 0.7× 258 1.6× 143 1.1× 61 0.6× 12 452
Kinga Bercsényi United Kingdom 8 272 0.9× 187 1.0× 148 0.9× 39 0.3× 64 0.7× 8 460
Scott Vermilyea United States 11 262 0.8× 133 0.7× 373 2.4× 38 0.3× 34 0.4× 19 564
Jeffrey Politsky United States 6 255 0.8× 209 1.1× 121 0.8× 35 0.3× 192 2.0× 6 493
Nicolas Mérienne France 11 309 1.0× 60 0.3× 337 2.1× 71 0.5× 107 1.1× 12 593
Tiago Cardoso Sweden 10 438 1.4× 108 0.6× 663 4.2× 104 0.8× 43 0.5× 14 838

Countries citing papers authored by Alistair Wilson

Since Specialization
Citations

This map shows the geographic impact of Alistair Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Wilson more than expected).

Fields of papers citing papers by Alistair Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Wilson. The network helps show where Alistair Wilson may publish in the future.

Co-authorship network of co-authors of Alistair Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Wilson. A scholar is included among the top collaborators of Alistair Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Wilson. Alistair Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Herzog, Christopher D., Lamar Brown, Alistair Wilson, et al.. (2013). Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120). Neurobiology of Disease. 58. 38–48. 33 indexed citations
2.
Herzog, Christopher D., Kathie M. Bishop, Lamar Brown, et al.. (2011). Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases. Drug Delivery and Translational Research. 1(5). 361–382. 25 indexed citations
3.
Bartus, Raymond T., Lamar Brown, Alistair Wilson, et al.. (2011). Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease. Neurobiology of Disease. 44(1). 38–52. 48 indexed citations
4.
Bartus, Raymond T., Christopher D. Herzog, Yaping Chu, et al.. (2010). Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains. Movement Disorders. 26(1). 27–36. 133 indexed citations
6.
Gasmi, Mehdi, Eugene P. Brandon, Christopher D. Herzog, et al.. (2007). AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease. Neurobiology of Disease. 27(1). 67–76. 117 indexed citations
7.
Opacka‐Juffry, Jolanta, Alistair Wilson, & Stavia B. Blunt. (1998). Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum. Brain Research. 810(1-2). 27–33. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026